Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide NIH notice about terminology changes during a website transition appears, and the footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-21T00:23:43.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-07T00:33:25.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The Revision entry has been updated to v3.7.0, replacing the previous v3.6.6. This indicates an underlying release update to the page rather than a change to study-related content.
    Difference
    0.0%
    Check dated 2026-09-23T00:25:09.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new 2026-09-04 history entry including a Study Status line and the value 447 was added. The 2026-08-04 entry was deleted.
    Difference
    0.0%
    Check dated 2026-09-08T22:43:37.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 is listed in the history, replacing the prior v3.6.5; this reflects a metadata update to the page rather than substantive changes to study data.
    Difference
    0.0%
    Check dated 2026-09-01T19:32:56.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The record history now shows the latest revision label as v3.6.5, replacing the previous v3.6.4. This reflects a metadata update to the study history rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-08-11T18:51:07.000Z thumbnail image

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.